AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 11%
#596 out of 5550 analysts
Average Return
+9.17%
Win Rate
42%87 out of 206
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kodiak Sciences IncKOD | +403.77% | $19.63 | $98.89 | 2025-11-11 - 2026-11-03 | Buy |
Opus Genetics IncIRD | +400.00% | $0.91 | $4.55 | 2025-04-01 - 2026-03-31 | Buy |
Kodiak Sciences IncKOD | +398.69% | $19.83 | $98.89 | 2025-11-17 - 2026-11-03 | Buy |
Phathom Pharmaceuticals IncPHAT | +335.14% | $2.76 | $12.01 | 2025-05-02 - 2026-05-01 | Buy |
Kodiak Sciences IncKOD | +324.06% | $23.32 | $98.89 | 2026-02-10 - 2026-11-03 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lenz Therapeutics IncLENZ | 11 | Buy | $16.00 | +357.14% | Maintains | 5 days ago |
4d Molecular Therapeutics IncFDMT | 21 | Buy | $36.00 | +201.26% | Reiterates | 13 days ago |
Zenas Biopharma IncZBIO | 9 | Buy | $44.00 | +55.04% | Reiterates | 22 days ago |
Kodiak Sciences IncKOD | 14 | Buy | $126.00 | +27.41% | Maintains | 23 days ago |
Mineralys Therapeutics IncMLYS | 14 | Buy | $56.00 | +250.22% | Reiterates | 23 days ago |
Aldeyra Therapeutics IncALDX | 15 | Hold | $2.00 | +222.06% | Reiterates | a month ago |
Surrozen IncSRZN | 7 | Buy | $54.00 | +79.28% | Maintains | a month ago |
Immunic IncIMUX | 9 | Buy | $22.00 | +189.47% | Reiterates | 2 months ago |
Opus Genetics IncIRD | 15 | Buy | $8.00 | +103.56% | Reiterates | 2 months ago |
Upstream Bio IncUPB | 2 | Buy | $36.00 | +961.95% | Reiterates | 2 months ago |
Diamedica Therapeutics IncDMAC | 8 | Buy | $12.00 | +20.00% | Reiterates | 3 months ago |
Fibrobiologics IncFBLG | 11 | Buy | $6.00 | +506.06% | Maintains | 3 months ago |
Phathom Pharmaceuticals IncPHAT | 13 | Buy | $26.00 | +352.96% | Reiterates | 3 months ago |
Tarsus Pharmaceuticals IncTARS | 4 | Buy | $88.00 | +21.15% | Reiterates | 4 months ago |
Akebia Therapeutics IncAKBA | 5 | Buy | $6.00 | +726.45% | Reiterates | 4 months ago |
Ardelyx IncARDX | 2 | Buy | $18.00 | +494.06% | Maintains | 8 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +14.68% | Downgrades | a year ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | N/A | Reiterates | a year ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | N/A | Downgrades | a year ago |
Optinose IncOPTN | 8 | Hold | $9.00 | N/A | Reiterates | a year ago |
Hillevax IncHLVX | 6 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 3 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 4 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.